15-17 April, 2019

The Waldorf Hilton

London, UK

 Discover, Translate & Clinically Validate Robustly Predictive Biomarkers & Maximise the Commercialisation, Access & Adoption of Drug-Dx Products

For its 10th year anniversary, Clinical Biomarkers & World CDx Europe is back to help the biomarker, diagnostic and precision medicine community translate clinically predictive biomarkers into proven IVDs to advance the standard of personalized care. Built for biomarker, translational, clinical, regulatory and commercial functions, Clinical Biomarkers & World CDx Europe is your end-to-end meeting for translating exploratory signatures into clinical useful biomarkers and overcoming key bottlenecks to driving adoption and access to game-changing diagnostic-enabled precision medicines.

Key topics for 2019:

symbol logo Identifying Truly Predictive Biomarkers. Evolving strategies for contextualizing and identifying truly predictive biomarker signatures.
symbol logo Clinical Biomarkers. Building the clinical studies to generate robust evidence to demonstrate the utility of biomarkers to support candidate development and approval registration.
symbol logo Universal Panel Diagnostics. Standardizing and deploying a new era of universal panel diagnostics to improve the identification and implementation of biomarkers and accelerate precision medicine deployment in the healthcare setting.
symbol logo European IVDR. Translating guidance into action: Understanding the impact of the new IVDR on a fractional European landscape and how to best build a safeguarded biomarker and diagnostic strategy for the future.

What 2018 Attendees Had to Say:

“Very much liked the size of the conference, the ability and time given to interact with other participants was much appreciated. From a personal note, I appreciated the Hanson Wade staff friendliness and genuine desire to help the Speakers and ensure the best experience for the attendees.”  Head, Clinical Trial Biosample Management, Merck KGaA

“Interesting, fast paced well organised. Very good meeting.”  Strategic Account Manager, AbbVie

“Great networking opportunity.”  Marketing Director CDx, AbbVie

“Educational, friendly, worthwhile.”  Translational Sciences Team Leader, GSK

“Vibrant collaboration opportunities.”  Clinical Senior Lecturer, Imperial College

“Great discussion engagement.” Senior Manager, Regulatory Affairs, Agios

“Good program, interested speakers, valuable discussion.” Associate Regulatory Affairs Director, Astellas

“Interesting introduction to CB and CDx for drug developers.” Regulatory Affairs, Autolus

 

9004 World CDx Who Attends Section